TLR8 and chronic hepatitis B virus infection: Gane Gane EJ EJ Kim Kim HJ HJ Visvanathan Visvanathan K K Safety, pharmacokinetics, and pharmacodynamics of the oral TLR8 agonist selgantolimod in chronic hepatitis B Safety, pharmacokinetics, and pharmacodynamics of the oral TLR8 agonist selgantolimod in chronic hepatitis B Hepatology Hepatology 2021 2021 74 74 1737 1737 1749 1749 10.1002/hep.31795 10.1002/hep.31795 33704806 33704806